HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cutaneous Manifestations of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

AbstractOBJECTIVE:
Cutaneous manifestations of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA), are poorly characterized. This report describes the dermatologic features of AAV and their association with systemic manifestations of vasculitis.
METHODS:
A cross-sectional study identifying and comparing the cutaneous manifestations of AAV was performed using data from a large, international, collaborative effort in order to collect comprehensive clinical data on patients with vasculitis.
RESULTS:
Data from 1,184 patients with AAV from 130 centers worldwide were available. Cutaneous manifestations were common in all AAV subtypes: GPA (223 of 656, or 34%), MPA (85 of 302, or 28%), and EGPA (106 of 226, or 47%). The most frequent cutaneous manifestation in AAV (all types) was petechiae/purpura, which was observed in 181 patients (15%). Allergic and nonspecific manifestations, such as pruritus, urticaria, and maculopapular rash, were more common in EGPA than in other disease subtypes (all P < 0.01). Skin biopsy, while underutilized (performed in 22-44% of patients), was frequently found to be an effective test suitable for diagnosis of AAV (diagnostic in 68-94% of patients). Compared to patients without cutaneous manifestations, those with skin lesions more frequently had severe systemic manifestations of vasculitis (such as alveolar hemorrhage and glomerulonephritis), specifically patients with GPA or EGPA and cytoplasmic/anti-proteinase 3 (anti-PR3) ANCA-positive or ANCA-negative patients (hazard ratio >1.9 for all), but not those with MPA or perinuclear/antimyeloperoxidase ANCAs.
CONCLUSION:
Cutaneous manifestations are common and varied in AAV and are associated with disease severity in patients with GPA, EGPA, cytoplasmic/anti-PR3 ANCA, or ANCA-negative disease. These findings underscore the potential diagnostic and prognostic importance of the cutaneous examination in the evaluation and management of AAV.
AuthorsRobert G Micheletti, Zelma Chiesa Fuxench, Anthea Craven, Richard A Watts, Raashid A Luqmani, Peter A Merkel, DCVAS Investigators
JournalArthritis & rheumatology (Hoboken, N.J.) (Arthritis Rheumatol) Vol. 72 Issue 10 Pg. 1741-1747 (10 2020) ISSN: 2326-5205 [Electronic] United States
PMID32419292 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2020, American College of Rheumatology.
Chemical References
  • Antibodies, Antineutrophil Cytoplasmic
Topics
  • Adult
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (complications, pathology)
  • Antibodies, Antineutrophil Cytoplasmic
  • Cross-Sectional Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pruritus (etiology, pathology)
  • Purpura (etiology, pathology)
  • Skin (pathology)
  • Urticaria (etiology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: